Applovin Plunges Short Sellers as AI Growth Questioned
AppLovin stock declines after fresh short-seller concerns about competition surface, even as Q4 numbers show strong c...
Review fee comparisons across wide market index funds to find the lowest-cost option for retirement. Practical guidance to reduce recurring expenses.
28,610 articlesAppLovin stock declines after fresh short-seller concerns about competition surface, even as Q4 numbers show strong c...
Rivian stock moved higher this week without a formal press release, boosted by direct investor outreach and renewed i...
Artificial intelligence is reshaping medicine, from drug discovery to patient care. This article spotlights two healt...
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Robinhood just announced a substantial $1.5 billion buyback. In this analysis, we weigh the potential benefits agains...
Citigroup stands out as the bank watchers' proxy on a rare earnings day for the big five. Markets look for signs on l...
Insider activity often sparks debate among investors. This article breaks down AXT's sold shares worth $1.41 million ...
Even as alkami stock down 50% frames a challenging chapter, a new large stake in Alkami Technology points to a differ...
Investors chasing solid returns in AI don’t have to chase sky-high premiums. This guide highlights three great value ...
Redwire shares have tumbled, leaving investors wondering if the decline is temporary or a warning. This guide explain...
CoreWeave stock is front and center as data-center demand rises. With a growing backlog and expanding capacity plans,...
ZoomInfo's go-to-market approach is evolving as 2026 unfolds. This analysis breaks down the GTM moves behind the earn...